June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Human Xylosyltransferase-1: A New Marker for Corneal Fibrosis Detection
Author Affiliations & Notes
  • Ratnakar Tripathi
    VMTH, University of Missouri, Columbia, Missouri, United States
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
  • Kaitlin E Smith
    Mason Eye Institute and VMTH, University of Missouri, Columbia, MO, United States., Columbia, Missouri, United States
  • Suneel Gupta
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
    VMTH, University of Missouri, Columbia, Missouri, United States
  • govindaraj anumanthan
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
    VMTH, University of Missouri, Columbia, Missouri, United States
  • Michael K Fink
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
    VMTH, University of Missouri, Columbia, Missouri, United States
  • Nishant R Sinha
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
    VMTH, University of Missouri, Columbia, Missouri, United States
  • Dishti Goyal
    VMTH, University of Missouri, Columbia, Missouri, United States
  • Rajiv R Mohan
    Mason Eye Institute and VMTH, University of Missouri, Columbia, MO, United States., Columbia, Missouri, United States
    Ophthalmology, Truman VA Hospital , Columbia, Missouri, United States
  • Footnotes
    Commercial Relationships   Ratnakar Tripathi, None; Kaitlin E Smith, None; Suneel Gupta, None; govindaraj anumanthan, None; Michael Fink, None; Nishant Sinha, None; Dishti Goyal, None; Rajiv Mohan, None
  • Footnotes
    Support  RO1EY17294
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Ratnakar Tripathi, Kaitlin E Smith, Suneel Gupta, govindaraj anumanthan, Michael K Fink, Nishant R Sinha, Dishti Goyal, Rajiv R Mohan; Human Xylosyltransferase-1: A New Marker for Corneal Fibrosis Detection. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal scarring (fibrosis) is characterized by the de novo formation of myofibroblast and extracellular matrix including proteoglycans. Human xylosyltransferase-1 (XT1) has been found to catalyze glycosaminoglycan biosynthesis at fibrotic onset in non-ocular tissues, however its expression and role in normal and fibrotic corneas is still unknown. We tested the hypothesis that XT1 can serve as a biomarker for corneal fibrotic remodeling. The specific aims were to: 1) characterize XT1 expression in normal and wounded human and rabbit corneas, 2) investigate its role in corneal wound healing, and 3) determine whether XT1 can serve as a biomarker for corneal fibrosis.

Methods : The normal and injured corneas of the New Zealand White rabbits under approved IACUC and donor human corneas (normal and diseased) exempt from IRB were used. Primary corneal fibroblast (HCF) and myofibroblast (HMF) cultures generated from normal donor human corneas were also used. HMF were produced by growing HCF in 5ng/ml transforming growth factor-β1 (TGFβ1) for 72h under serum-free conditions. Immunofluorescence, H&E, immunoblotting, and real-time quantitative PCR analyzed mRNA and protein levels of selected genes. The α-smooth muscle actin (αSMA), a well acceptable myofibroblast marker in corneal field, was used as a control in comparative studies.

Results : Normal rabbit and human corneas showed no expression of XT1 and αSMA. Conversely, wounded (alkali burn and photorefractive keratectomy applied) rabbit corneas showed significantly high levels of XT1 and αSMA mRNA expression (p<0.01). Immunofluorescence detected significant number of αSMA+ and XT1+ cells in wounded rabbit corneas than uninjured corneas. It is note that XT1 mRNA levels were >100 folds higher than the αSMA. TGFβ1 treated HCF showed significantly higher levels of XT1 and αSMA mRNA levels compared to untreated HCF (p<0.01). HMF cultures showed much greater levels of XT1 compared to αSMA mRNA (5-35 fold; p<0.01) in time-dependent manner (4h-7days).

Conclusions : XT1 may serve as a biomarker for corneal fibrosis. Future studies will test the potential of XT1 for mitigating corneal scarring.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×